MDNA.TO
Medicenna Therapeutics Corp
Price:  
1.08 
CAD
Volume:  
444,287.00
Canada | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MDNA.TO WACC - Weighted Average Cost of Capital

The WACC of Medicenna Therapeutics Corp (MDNA.TO) is 7.4%.

The Cost of Equity of Medicenna Therapeutics Corp (MDNA.TO) is 11.20%.
The Cost of Debt of Medicenna Therapeutics Corp (MDNA.TO) is 5.00%.

Range Selected
Cost of equity 8.70% - 13.70% 11.20%
Tax rate 25.90% - 26.50% 26.20%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.2% - 8.7% 7.4%
WACC

MDNA.TO WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 5.1% 6.1%
Adjusted beta 1.1 1.56
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.70% 13.70%
Tax rate 25.90% 26.50%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.2% 8.7%
Selected WACC 7.4%